WO2014129884A3 - Composition with inhibitory effect on viral integrase activity - Google Patents

Composition with inhibitory effect on viral integrase activity Download PDF

Info

Publication number
WO2014129884A3
WO2014129884A3 PCT/MY2014/000019 MY2014000019W WO2014129884A3 WO 2014129884 A3 WO2014129884 A3 WO 2014129884A3 MY 2014000019 W MY2014000019 W MY 2014000019W WO 2014129884 A3 WO2014129884 A3 WO 2014129884A3
Authority
WO
WIPO (PCT)
Prior art keywords
composition
inhibitory effect
integrase activity
viral integrase
nutraceutical
Prior art date
Application number
PCT/MY2014/000019
Other languages
French (fr)
Other versions
WO2014129884A2 (en
Inventor
Ravigadevi Sambanthamurthi
Yew Ai Tan
Md Ali JABARIAH
Saridah Wan Omar WAN
Original Assignee
Malaysian Palm Oil Board
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Malaysian Palm Oil Board filed Critical Malaysian Palm Oil Board
Publication of WO2014129884A2 publication Critical patent/WO2014129884A2/en
Publication of WO2014129884A3 publication Critical patent/WO2014129884A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Present invention relates to a composition comprising extracts from oil palm in preventing and treating viral infection and related diseases. The composition may be provided as compounds with pharmaceutically acceptable carriers, in effective dosage forms of solid, liquid, solution, nutraceutical, nutritional supplementary and suppository form. The composition may be administered orally and by intravenous.
PCT/MY2014/000019 2013-02-21 2014-02-19 Composition with inhibitory effect on viral integrase activity WO2014129884A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
MYPI2013700282 2013-02-21
MYPI2013700282A MY178049A (en) 2013-02-21 2013-02-21 Composition with inhibitory effect on viral integrase activity

Publications (2)

Publication Number Publication Date
WO2014129884A2 WO2014129884A2 (en) 2014-08-28
WO2014129884A3 true WO2014129884A3 (en) 2014-10-16

Family

ID=51391944

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/MY2014/000019 WO2014129884A2 (en) 2013-02-21 2014-02-19 Composition with inhibitory effect on viral integrase activity

Country Status (2)

Country Link
MY (1) MY178049A (en)
WO (1) WO2014129884A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2560710B (en) * 2017-03-17 2021-10-20 Malaysian Palm Oil Board Compositions comprising oil palm phenolics and shikimic acid or derivatives thereof and uses thereof
WO2018165780A1 (en) * 2017-03-17 2018-09-20 Malaysian Palm Oil Board Antioxidant, anti-inflammatory compositions and uses thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009014417A2 (en) * 2007-07-23 2009-01-29 Malaysian Palm Oil Board An antiviral composition
WO2011159144A1 (en) * 2010-06-16 2011-12-22 Malaysian Palm Oil Board Compositions comprising shikimic acid obtained from oil palm based materials and method of producing thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009014417A2 (en) * 2007-07-23 2009-01-29 Malaysian Palm Oil Board An antiviral composition
WO2011159144A1 (en) * 2010-06-16 2011-12-22 Malaysian Palm Oil Board Compositions comprising shikimic acid obtained from oil palm based materials and method of producing thereof

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
OGUNTIBEJU, 0. 0. ET AL.: "Possible role of red palm oil supplementation in reducing oxidative stress in HIV/AIDS and TB patients: a review", JOURNAL OF MEDICINAL PLANTS RESEARCH, vol. 4, no. 3, 2010, pages 188 - 196 *
SAKLANI, A. ET AL.: "Plant-derived compounds in clinical trials", DRUG DISCOVERY TODAY, vol. 13, no. 3 / 4, 2008, pages 161 - 171 *
WANG, R.-R. ET AL.: "Anti-HIV-1 activities of compounds isolated from the medicinal plant Rhus chinensis", JOURNAL OF ETHNOPHARMACOLOGY, vol. 117, 2008, pages 249 - 256, XP022614075, DOI: doi:10.1016/j.jep.2008.01.037 *

Also Published As

Publication number Publication date
MY178049A (en) 2020-09-30
WO2014129884A2 (en) 2014-08-28

Similar Documents

Publication Publication Date Title
WO2014205389A8 (en) Nuclear transport modulators and uses thereof
HK1218110A1 (en) Sulfamoyl arylamides and the use thereof as medicaments for the treatment of hepatitis b
WO2011113013A3 (en) Methods and compositions for treating viral or virally-induced conditions
WO2013170068A3 (en) Nuclear transport modulators and uses thereof
MX2016005482A (en) Immediate release abuse-deterrent granulated dosage forms.
WO2015077503A8 (en) Autotaxin inhibitor compounds
CL2015000784A1 (en) Compounds derived from acylaminopyrimidine, interferon inducers; pharmaceutical composition that includes them; its use in the treatment of viral infections, immune disorders, cancer and other diseases.
CL2013003372A1 (en) Compounds derived from spiro- [1,3] -oxacins and spiro- [1,4] -oxacepins, inhibitors of bace1 and / or bace2; pharmaceutical composition; procedure to prepare them; and its use in the treatment and / or prophylaxis of Alzheimer's disease and diabetes.
MX2022009352A (en) Nucleotide hemi-sulfate salt for the treatment of hepatitis c virus.
PH12014501967A1 (en) Benzodioxanes in combination with other actives for inhibiting leukotriene production
WO2017022962A8 (en) Composition for preventing or treating immune disease, comprising ripk inhibitor as active ingredient
PH12017500747B1 (en) Heterocyclic compound
WO2015058664A8 (en) Use of icaritin in preparing medicament for preventing or treating hematocytopenia
PH12015502406A1 (en) Orally administrable pharmaceutical composition for prevention or treatment of dry eye syndrome, comprising rebamipide or prodrug thereof
MX2022001796A (en) Methods and compositions to inhibit symptoms associated with veisalgia.
IN2013MU00711A (en)
WO2014145686A3 (en) Novel cyclosporin derivatives and uses thereof
ES2429422R1 (en) Pharmaceutical composition and its use to prepare a medicine for the treatment and prevention of HIV diseases
WO2016089206A3 (en) Selective il-6-trans-signalling inhibitor compositions
WO2015126129A3 (en) Resveratrol multimer having selective inhibitory activity for hepatitis c virus genome replication, and use thereof
WO2016108572A3 (en) Composition for preventing and treating cholesterol-related diseases
WO2014129884A3 (en) Composition with inhibitory effect on viral integrase activity
MX2018006631A (en) Compound for use in the prevention and treatment of neurodegenerative diseases.
WO2015077693A3 (en) Use of microrna 146-a in the diagnosis, treatment and prevention of picornavirus infection and microran 146-a antagonists
TW201613606A (en) Therapeutic drug for chronic renal failure

Legal Events

Date Code Title Description
122 Ep: pct application non-entry in european phase

Ref document number: 14753593

Country of ref document: EP

Kind code of ref document: A2